Pricing Log in Create free account

Neuphoria Therapeutics Inc. (NEUP) vs Radiopharm Theranostics Limited - Sponsored ADR (RADX)

Neuphoria Therapeutics Inc. and Radiopharm Theranostics Limited - Sponsored ADR are both Biotechnology companies. Neuphoria Therapeutics Inc. and Radiopharm Theranostics Limited - Sponsored ADR are of similar size ($17.9M and $17.0M). Across the 7 metrics below, Radiopharm Theranostics Limited - Sponsored ADR leads on 6 and Neuphoria Therapeutics Inc. on 1.

Valuation

Metric NEUP RADX Biotechnology median
P/E n/m — 8.50
P/S 0.91 — 9.71
P/B 0.58 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.27 n/m 0.64
EV/Sales (0.30) n/m 9.21
Earnings yield (154.60%) — (33.15%)
Free cash flow yield (85.14%) 0.00% (25.50%)

Profitability

Metric NEUP RADX Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (61.70%) 0.00% (56.36%)
Return on assets (46.95%) 0.00% (48.04%)
Return on invested capital (232.67%) 0.00% 0.00%

Growth

Metric NEUP RADX Biotechnology median
Revenue growth (TTM) 3,535.05% — 6.02%
EPS growth (last fiscal year) (1,230.43%) (1.97%) 30.26%
Revenue growth, 5-year CAGR 19.07% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric NEUP RADX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 27.85 1.16 4.72
Net debt to EBITDA 1.26 0.08 0.96

Dividend

Metric NEUP RADX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric NEUP RADX Biotechnology median
Market cap 17.91m 16.96m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack